2U3:FRA
Alcon AG
€56.96
arrow_downward
-0.21%(-0.12) 1D
Oct 5, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2U3...
Open
€56.44
High
€56.96
Low
€56.44
Mkt. cap
26.46B
Avg. vol.
210.00
Volume
103.00
52-wk high
€73.96
52-wk low
€51.78
No. of employees
25K
Open
€56.44
High
€56.96
Low
€56.44
Mkt. cap
26.46B
Avg. vol.
210.00
Volume
103.00
52-wk high
€73.96
52-wk low
€51.78
No. of employees
25K
News stories
From web sources and news partners
AD HOC NEWS
·
4 hours ago
Alcon stock after-hours at EUR 57.18: plus 1.08 percent versus prior close
AD HOC NEWS
·
7 hours ago
Alcon stock gets a new weekly lens launch in October 2026
AD HOC NEWS
·
11 hours ago
Alcon announces Academy research. Alcon stock sits 23.02 percent below its 52-week high
AD HOC NEWS
·
14 hours ago
Alcon stock pre-market at EUR 56.31: minus 0.46 percent
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorMedical device
Websitealcon.com